Vimarsana
Biggest News Aggregation in the World

Aston Sci Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aston Sci Inc . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aston Sci Inc Today - Breaking & Trending Today

US FDA Approves Aston Sci.'s Phase 2 IND for Ovarian Cancer Vaccine, AST-201 - Vimarsana News

US FDA Approves Aston Sci.'s Phase 2 IND for Ovarian Cancer Vaccine, AST-201

Published: September 12, 2023

/PRNewswire/ -- Aston Sci. is proud to announce that it has received Phase 2 Clinical Investigational New Drug (IND) approval from the U.S. Food and Drug...

Source: prnewswire.com
Related Topics:
United StatesSoult UkpyolsiSouth KoreaShun JungPublic AffairsRd Division At Aston SciDrug AdministrationNew Vaccine ApproachOvarian CancerInvestigational New DrugPrimary ObjectivePipeline ExpansionOvarian Cancer PatientsAston Sci Inc
Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer - Vimarsana News

Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer

Published: September 2, 2022

/PRNewswire/ -- Aston Sci. Inc., a clinical stage biopharmaceutical company specializing in clinical development of therapeutic cancer vaccines, announced that...

Source: prnewswire.com
Related Topics:
Soult UkpyolsiSouth KoreaUnited StatesMaryl Nora DisisEun Kyo JoungUniversity Of WashingtonAmerican Society Of Clinical OncologyRegulatory AffairsDrug AdministrationAmerican SocietyClinical OncologyRegulatory Affairs DirectorKyo JoungChief Medical OfficerAston SciAston Sci Inc Medical Pharmaceuticals Health Care Amp Hospitals Pharmaceuticals Biotechnology Fda ApprovalClinical Trials Amp Medical Discoveries